Developing drugs to treat osteoporosis: lessons learned? (2010)
- Authors:
- Autor USP: PAULA, FRANCISCO JOSE ALBUQUERQUE DE - FMRP
- Unidade: FMRP
- DOI: 10.1517/14656560903575662
- Subjects: OSTEOPOROSE (TRATAMENTO); FÁRMACOS
- Language: Inglês
- Source:
- Título: Expert Opinion on Pharmacotherapy
- ISSN: 1465-6566
- Volume/Número/Paginação/Ano: v. 11, n. 5, p. 867-869, 2010
- Este artigo NÃO possui versão em acesso aberto
-
Status: Nenhuma versão em acesso aberto identificada -
ABNT
PAULA, Francisco Jose Albuquerque de e ROSEN, Clifford J. Developing drugs to treat osteoporosis: lessons learned?. Expert Opinion on Pharmacotherapy, v. 11, n. 5, p. 867-869, 2010Tradução . . Disponível em: https://doi.org/10.1517/14656560903575662. Acesso em: 14 mar. 2026. -
APA
Paula, F. J. A. de, & Rosen, C. J. (2010). Developing drugs to treat osteoporosis: lessons learned? Expert Opinion on Pharmacotherapy, 11( 5), 867-869. doi:10.1517/14656560903575662 -
NLM
Paula FJA de, Rosen CJ. Developing drugs to treat osteoporosis: lessons learned? [Internet]. Expert Opinion on Pharmacotherapy. 2010 ; 11( 5): 867-869.[citado 2026 mar. 14 ] Available from: https://doi.org/10.1517/14656560903575662 -
Vancouver
Paula FJA de, Rosen CJ. Developing drugs to treat osteoporosis: lessons learned? [Internet]. Expert Opinion on Pharmacotherapy. 2010 ; 11( 5): 867-869.[citado 2026 mar. 14 ] Available from: https://doi.org/10.1517/14656560903575662 - Bone remodeling and energy metabolism: new perspectives
- The intravenous glucose tolerance and postprandial glucose tests may present different responses in the evaluation of obese dogs
- DXA, bioelectrical impedance, ultrasonography and biometry for the estimation of fat and lean mass in cats during weight loss
- Bone phenotype in heterozigous for a mutation in the GHRH receptor gene
- Consequences of lifetime isolated growth hormone (GH) deficiency and effects of short-ter GH treatment on bone in adults with a mutation in the GHRH-receptor gene
- Comportamento metabolico do tecido muscular em individuos com hiperprolactinemia e em mulheres com hiperandrogenismo por hiperplasia adrenal congenita
- VDR haploinsuficiency impacts body composition and skeletal acquisition in a gender-specific manner
- Osteoporosis
- Heterozygosity in the VTR gene influences body composition more than bone mass
- Influence of primary hypoparathyroidism (PHp) on bone mineral density (BMD) and vertebral morphometry
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
